Literature DB >> 8068941

Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit.

D J Kuter1, R D Rosenberg.   

Abstract

Plasma obtained from rabbits made thrombocytopenic by the injection of antiplatelet serum (APS) stimulated megakaryocyte growth in an in vitro bone marrow culture. Although the number of megakaryocytes that grew was increased on average to 136%, the major effect was on megakaryocyte ploidy, which showed a shift in the modal ploidy class from 8N to 16N, an average change in the geometric mean ploidy from 8.7N to 11.8N, and the appearance of some 64N megakaryocytes. This in vitro stimulation of megakaryocyte number and ploidy was shown to be due to the appearance in the circulation of a positive activity, which we have named megapoietin. Levels of megapoietin in thrombocytopenic plasma could be quantitated by measuring the extent of megakaryocyte ploidization in vitro. The relationship over time of megapoietin to changes in the platelet count was then assessed in a series of rabbits made thrombocytopenic by APS injection. Although not elevated after 3 hours of thrombocytopenia, megapoietin increased after 8 hours to 48% of the maximal level, which occurred after 24 hours of thrombocytopenia. Levels of megapoietin were inversely and proportionally related to the platelet count during thrombocytopenia and the subsequent rebound thrombocytosis. During persistent thrombocytopenia, megapoietin levels remained maximally elevated. These results suggest that megapoietin may play a physiologic role in the feedback loop between the platelet and the bone marrow megakaryocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068941

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  A role for cyclin D3 in the endomitotic cell cycle.

Authors:  J M Zimmet; D Ladd; C W Jackson; P E Stenberg; K Ravid
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

2.  Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis.

Authors:  V R Deutsch; A Eldor; T Olson; V Barak; M Pick; A Nagler
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

Review 3.  New thrombopoietic growth factors.

Authors:  David J Kuter
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

4.  The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.

Authors:  D J Kuter; D L Beeler; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

6.  Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrombocytopenia.

Authors:  Benjamin T Kile; Athanasia D Panopoulos; Roslynn A Stirzaker; Douglas F Hacking; Lubna H Tahtamouni; Tracy A Willson; Lisa A Mielke; Katya J Henley; Jian-Guo Zhang; Ian P Wicks; William S Stevenson; Paquita Nurden; Stephanie S Watowich; Monica J Justice
Journal:  Blood       Date:  2007-05-21       Impact factor: 22.113

7.  Thrombopoietin receptor levels in tumor cell lines and primary tumors.

Authors:  Connie L Erickson-Miller; Antony Chadderton; Anna Gibbard; Jennifer Kirchner; Kodandaram Pillarisetti; Katherine Baker; Lini Pandite; Iman El-Hariry; Yasser Mostafa Kamel; Yuan Liu; Anne-Marie Martin; Conrad Messam
Journal:  J Oncol       Date:  2010-12-28       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.